Prevalence of Parent-Reported ADHD Diagnosis and Associated Treatment Among U.S. Children and Adolescents, 2016.
Prevalence of Parent-Reported ADHD Diagnosis and Associated Treatment Among U.S. Children and Adolescents, 2016.
复制标题
DOI：
10.1080/15374416.2017.1417860
复制
发表时间：
2018-03
期刊：
影响因子：
--
通讯作者：
Blumberg SJ
中科院分区：
文献类型：
--
作者：
Danielson ML;Bitsko RH;Ghandour RM;Holbrook JR;Kogan MD;Blumberg SJ
本研究的目的是利用2016年全国儿童健康调查（NSCH）估计美国2-17岁儿童中家长报告的注意缺陷/多动障碍（ADHD）诊断和治疗的全国患病率。NSCH是一项具有全国代表性的家长关于孩子健康的横断面调查，在2016年数据收集之前进行了重新设计。它包括一生中接受卫生保健提供者的ADHD诊断的指标，儿童目前是否患有ADHD，以及接受ADHD药物和行为治疗的指标。加权患病率估计值计算总体和人口统计学和临床亚组（n = 45,736）。2016年，估计有610万2-17岁的美国儿童（9.4%）曾被诊断为多动症。其中，目前有540万人患有多动症，占被诊断患有多动症儿童的89.4%，占美国2-17岁儿童的8.4%。在目前患有多动症的儿童中，近三分之二（62.0%）正在服用药物，略少于一半（46.7%）的儿童在过去一年中接受过多动症的行为治疗；近四分之一（23.0%）未接受任何治疗。与先前调查的估计类似，有大量的美国儿童和青少年被卫生保健提供者诊断患有多动症。这些儿童中的许多人（但不是全部）接受的治疗似乎符合专业指导方针，尽管调查问题对所接受的具体治疗类型的细节有限。重新设计的NSCH可用于每年监测这种高度流行和高影响的神经发育障碍的诊断和治疗模式。
The purpose of this study is to estimate the national prevalence of parent-reported attention deficit/hyperactivity disorder (ADHD) diagnosis and treatment among U.S. children 2–17 years of age using the 2016 National Survey of Children’s Health (NSCH). The NSCH is a nationally representative, cross-sectional survey of parents regarding their children’s health that underwent a redesign before the 2016 data collection. It included indicators of lifetime receipt of an ADHD diagnosis by a health care provider, whether the child currently had ADHD, and receipt of medication and behavioral treatment for ADHD. Weighted prevalence estimates were calculated overall and by demographic and clinical subgroups (n = 45,736). In 2016, an estimated 6.1 million U.S. children 2–17 years of age (9.4%) had ever received an ADHD diagnosis. Of these, 5.4 million currently had ADHD, which was 89.4% of children ever diagnosed with ADHD and 8.4% of all U.S. children 2–17 years of age. Of children with current ADHD, almost two thirds (62.0%) were taking medication and slightly less than half (46.7%) had received behavioral treatment for ADHD in the past year; nearly one fourth (23.0%) had received neither treatment. Similar to estimates from previous surveys, there is a large population of U.S. children and adolescents who have been diagnosed with ADHD by a health care provider. Many, but not all, of these children received treatment that appears to be consistent with professional guidelines, though the survey questions are limited in detail about specific treatment types received. The redesigned NSCH can be used to annually monitor diagnosis and treatment patterns for this highly prevalent and high-impact neurodevelopmental disorder.
登录
查看更多内容
DOI：
10.1016/j.jaac.2014.10.014
发表时间：
2015-01
影响因子：
13.3
作者：
McKeown, Robert E.;Holbrook, Joseph R.;Danielson, Melissa L.;Cuffe, Steven P.;Wolraich, Mark L.;Visser, Susanna N.
通讯作者：
Visser, Susanna N.
影响因子：
6.9
作者：
Matte, B.;Anselmi, L.;Salum, G. A.;Kieling, C.;Goncalves, H.;Menezes, A.;Grevet, E. H.;Rohde, L. A.
通讯作者：
Rohde, L. A.
影响因子：
2.1
作者：
Fletcher, Jason M.
通讯作者：
Fletcher, Jason M.
影响因子：
8
作者：
Morgan, Paul L.;Staff, Jeremy;Maczuga, Steven
通讯作者：
Maczuga, Steven
DOI：
10.1016/j.jaac.2012.12.014
发表时间：
2013-03
影响因子：
13.3
作者：
Molina BS;Hinshaw SP;Eugene Arnold L;Swanson JM;Pelham WE;Hechtman L;Hoza B;Epstein JN;Wigal T;Abikoff HB;Greenhill LL;Jensen PS;Wells KC;Vitiello B;Gibbons RD;Howard A;Houck PR;Hur K;Lu B;Marcus S;MTA Cooperative Group
通讯作者：
MTA Cooperative Group